You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Compugen appoints chief medical officer
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
Compugen Ltd. appointed Henry Adewoye to the newly created role of chief medical officer, effective March 26.
Adewoye most recently served as clinical director in oncology clinical research at Gilead Sciences Inc.
Tel Aviv-based Compugen is a therapeutic discovery and development company working to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.